RANDOMIZED PHASE II TRIAL OF CARBOPLATIN-PACLITAXEL COMPARED TO CARBOPLATIN-PACLITAXEL-TRASTUZUMAB IN ADVANCED (STAGE III-IV) OR RECURRENT UTERINE SEROUS CARCINOMA: RESULTS OF INTERIM ANALYSIS (NCT01367002)

2016 ◽  
Author(s):  
Alessandro D Santin
Keyword(s):  
Phase Ii ◽  
Interim Analysis ◽  
Phase Ii Trial ◽  
Stage Iii ◽  
Serous Carcinoma ◽  
Advanced Stage ◽  
Randomized Phase Ii ◽  
Uterine Serous Carcinoma

scholarly journals Randomized Phase II Trial of Triapine-Cisplatin-Radiotherapy for Locally Advanced Stage Uterine Cervix or Vaginal Cancers

2019 ◽  
Vol 9 ◽  
Author(s):  
Charles A. Kunos ◽  
Stephen J. Andrews ◽  
Kathleen N. Moore ◽  
Hye Sook Chon ◽  
S. Percy Ivy
Keyword(s):  
Phase Ii ◽  
Uterine Cervix ◽  
Phase Ii Trial ◽  
Locally Advanced ◽  
Advanced Stage ◽  
Randomized Phase Ii

Randomized phase II trial evaluating treatment with EGFR-TKI versus EGFR-TKI associated with anti-estrogen in women with non-squamous advanced stage NSCLC: IFCT-1003 LADIE trial.

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. 9097-9097 ◽  
Author(s):  
Julien Mazieres ◽  
Fabrice Barlesi ◽  
Isabelle Rouquette ◽  
Benjamin Besse ◽  
Isabelle Monnet ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Trial ◽  
Advanced Stage ◽  
Randomized Phase Ii ◽  
Egfr Tki

A phase II trial of the Wee1 inhibitor adavosertib (AZD1775) in recurrent uterine serous carcinoma

2020 ◽  
Vol 159 ◽  
pp. 5
Author(s):  
J.F. Liu ◽  
N. Tayob ◽  
S.M. Campos ◽  
A.A. Wright ◽  
C. Krasner ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Trial ◽  
Serous Carcinoma ◽  
Uterine Serous Carcinoma

scholarly journals MA05.07 Dose Escalated Chemo-RT to 84 Gy in Stage III NSCLC Appears Excessively Toxic: Results from a Randomized Phase II Trial

2018 ◽  
Vol 13 (10) ◽  
pp. S373
Author(s):  
J. Nyman ◽  
S. Bergström ◽  
H. Björkestrand ◽  
A. Svärd ◽  
S. Ekman ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Trial ◽  
Stage Iii ◽  
Randomized Phase Ii ◽  
Stage Iii Nsclc
Sign in / Sign up

Export Citation Format

Share Document